Tricou V, Eyre S, Ramjee M, Collini P, et al. A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country. Vaccine 2023 Jan 19:S0264-410X(23)00007-5. doi: 10.1016/j.vaccine.2023.
PMID: 36681529